Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Clinical Genitourinary Cancer Stories

2012-02-09 08:00:00

WALTHAM, Mass., Feb. 9, 2012 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that scientists at Roswell Park Cancer Institute have demonstrated that entinostat, Syndax's novel, oral small molecule inhibitor of class I histone deacetylases, has novel immunomodulatory properties that contribute to the enhanced activity of cancer immunotherapies in models of renal and prostate cancer. The results were published in PLoS ONE...

2011-11-08 09:17:00

BETHLEHEM, Pa., Nov. 8, 2011 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Li Zhang, M.D., has been appointed to the company's scientific advisory board (SAB). Dr. Zhang is a professor of medical oncology and deputy director of the Lung Cancer Research Centre of Sun Yat-Sen University (SYSU),...

2011-11-07 07:24:00

CLEVELAND, Nov. 7, 2011 /PRNewswire/ -- Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin - Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals as national leaders in teaching, research, and patient care in the field of integrative oncology. The gifts from The Parker Foundation and Helen Moss Cancer...

2011-11-01 09:17:00

BETHLEHEM, Pa., Nov. 1, 2011 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Edward Chu, M.D., has accepted to chair the company's scientific advisory board (SAB). Dr. Chu, who serves as chief of the Division of Hematology/Oncology in the Department of Medicine at the University of Pittsburgh School of Medicine,...

2011-08-13 00:00:29

Prostate Cancer Treatment Specialist Stephen J. M. Banks, M.D., Has Joined the Martin-O'Neil Cancer Center Team at St. Helena Hospital. St. Helena, CA (PRWEB) August 12, 2011 St. Helena Hospital's Martin-O'Neil Cancer Center (MOCC) welcomes Dr. Stephen J. M. Banks, M.D. as a member of its Radiation Oncology team. Nationally recognized for his clinical expertise and his contributions to advances in the field of radiation oncology, Dr. Banks specializes in the treatment of prostate cancer...

2011-06-04 00:00:31

The Society for Translational Oncology (STO) is honored to award the 2011 Bob Pinedo Cancer Care Prize to Dr. Gabriel N. Hortobágyi, Nellie B. Connally Chair, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center. Dr. Hortobágyi is awarded the prize for his life-long dedication to cancer patients and his pioneering progress in bringing new hope to breast cancer patients. Durham, NC (PRWEB) June 02, 2011 The Society for Translational Oncology (STO) is...

2011-02-02 12:00:00

CAMBRIDGE, Mass., Feb. 2, 2011 /PRNewswire/ -- Metamark Genetics, Inc., a privately-held oncology molecular diagnostics company, today announced results from a landmark prostate cancer study published as an Advance Online Publication in the journal Nature. The study describes the identification of a key tumor suppressor of prostate cancer progression in mice and humans, as well as reveals four markers that are predictive of biochemical recurrence and lethal metastasis in human prostate...

2011-01-18 16:35:00

BEVERLY HILLS, Calif., Jan. 18, 2011 /PRNewswire/ -- Tower Cancer Research Foundation, a nonprofit organization dedicated to cutting edge cancer therapy and research, will host the second in its series of free symposiums on March 8. The 2011 Tower Oncology Winter Cancer Symposium - Advances in Colon and Rectal Cancer Research and Treatment: A Multidisciplinary Panel Discussion - will take place from 7:00-9:00pm at the Pacific Design Center, 8687 Melrose Blvd., West Hollywood, Calif. The...

2010-11-10 07:00:00

HOUSTON, Nov. 10, 2010 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc., a company developing novel therapies that can be precisely controlled after delivery, today announced the appointment of four new members to its Clinical Advisory Board (CAB). The new appointments enhance the range and depth of expertise of the CAB, which provides medical and strategic guidance for the company's product development and commercialization activities that include two programs in clinical trials. The...

2010-10-29 13:05:00

Abstract # 1586 SAN DIEGO, Oct. 29 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting. (Logo:...


Latest Clinical Genitourinary Cancer Reference Libraries

Clinical Genitourinary Cancer
2012-05-18 15:47:47

Clinical Genitourinary Cancer is a peer-reviewed medical journal published by CIG Media Group. The journal was previously published as Clinical Prostate Cancer through September 2005. Clinical Genitourinary Cancer publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. It is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in...

Clinical Ovarian Cancer
2012-05-18 14:46:55

Clinical Ovarian Cancer is a peer-reviewed medical journal published by CIG Media Group. It is devoted to articles on detection, diagnosis, prevention, and treatment of ovarian cancer. The main emphasis is on recent scientific developments in all areas pertaining to ovarian cancer. Specific areas or interest include clinical research, drug sensitivity and resistance, gene therapy, pathology, markers, prognostic indicators, chemoprevention strategies, multimodality therapy; and integration...

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (3 articles) »